Concepedia

Özgecan Dülgar

ÖD

4

Publications

76

Citations

4

H-Index

2020

Active since

Affiliations

Marmara University(Current)

Moffitt Cancer Center

Istanbul University

Özgecan Dülgar is an author at Marmara University specializing in medicine, immunology, and tumor biology.

ORCID

Top concepts

Publications per year

2020–2023

4

Publications

4

Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Seda Kahraman, Enes Erul, Mustafa Seyyar et al. · Future Oncology · 2023 · 21 citations · Full text

Mechanisms of Resistance to BRAF-Targeted Melanoma Therapies

Özgecan Dülgar, Tuğçe Kütük, Zeynep Eroglu · American Journal of Clinical Dermatology · 2020 · 20 citations

, , +4

Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy

Prachi Bhave, Angela Hong, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2023 · 18 citations · Full text

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer

Seval Ay, Muhammed Mustafa Atçı, Rukiye Arıkan et al. · Journal of Chemotherapy · 2022 · 17 citations

, , +16

Rows per page

1–4 of 4